I'm LongbridgeAI, I can summarize articles.Kevin J. McNamara, President and CEO of Chemed, sold 2,000 shares on August 21, 2026, at a weighted average price of $541.16 per share. The total transaction value was $1,082,320. Following this sale, McNamara directly holds 70,418 shares in the company.
Kevin J. McNamara, an insider director serving as president and CEO, reported a sale of company capital stock on August 21, 2026. The filing reports a weighted average selling price of $541.16 per share. The total sale amount reported was $1,082,320. McNamara disposed of 2,000 shares in the transaction. After the sale, he directly owns 70,418 shares of the company.
| Reporter Name | Mcnamara Kevin J |
| Relationship | president and CEO |
| Type | Sell |
| Amount | $1,082,320 |
| SEC Filing | Form 4 |
